Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
H

Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627

Watchlist Manager
Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
Watchlist
Price: 1.58 CNY Market Closed
Market Cap: ¥7.7B
Write Note Create Alert Ask AI

Relative Value

The Relative Value of one Hubei Biocause Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 1.58 CNY, Hubei Biocause Pharmaceutical Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Hubei Biocause Pharmaceutical Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

P/S
View Details
P/E
View Details
P/B
View Details
Price/Premiums
View Details

Multiples Across Competitors

Competitors Multiples
Hubei Biocause Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
P/B
All Countries
All Countries
Close
Market Cap P/S P/E P/B
CN
Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
7.8B CNY 0.2 -10.1 0.4
ZA
Sanlam Ltd
JSE:SLM
211.5B ZAR 1.6 9.4 2.1
CN
China Life Insurance Co Ltd
SSE:601628
1.4T CNY 3.6 8 2.2
CN
Ping An Insurance Group Co of China Ltd
SSE:601318
1.2T CNY 1.4 8.6 1.2
ZA
Discovery Ltd
JSE:DSY
160.2B ZAR 1.8 17.2 2.4
HK
AIA Group Ltd
HKEX:1299
885.1B HKD 4.4 18.7 2.8
ZA
OUTsurance Group Ltd
JSE:OUT
114.5B ZAR 3 24.3 7.9
ZA
Old Mutual Ltd
JSE:OMU
68B ZAR 0.4 10.4 1.1
CA
Manulife Financial Corp
TSX:MFC
87.1B CAD 2.2 16.1 1.7
IN
Life Insurance Corporation Of India
NSE:LICI
5.6T INR 0.6 10.5 3.9
US
Aflac Inc
NYSE:AFL
60.3B USD 3.5 16.6 2

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 317,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.